NCT06625047 - Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Astrocytoma, IDH-MutantGlioblastomaGliomaOligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Interventions

BEHAVIORAL

Assessment

Complete in-person assessment visits

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Telemedicine Visit

Complete telehealth assessment visits

DRUG

Temozolomide

Given PO

Trial Locations (1)

RECRUITING

Mayo Clinic in Rochester, Rochester